Davies Adeloye is the UK principal investigator for the C²REST Nigeria Study. He is a medical doctor and epidemiologist. He has over 10 years of experience in clinical practice, research, and teaching in the United Kingdom and Africa. He obtained his PhD in global health epidemiology from the University of Edinburgh in 2015. He then went on to lead the Global Health Epidemiology Research Group (GHERG) in Nigeria, where he focused on the burden of non-communicable diseases (NCDs) in Africa.
In 2018, he developed the NCDs data profile for Nigeria, a project commissioned by the World Health Organization and the Nigerian Federal Ministry of Health. He is a recipient of the US Carnegie fellowship, the American Association for Cancer Research (AACR) for African researchers, and the African Organization for Research and Training in Cancer (AORTIC) Leadership Institute Award. His main research interest is the global burden of chronic respiratory diseases, such as COPD, asthma, allergies, and lung cancer. He has led international research collaborations on the global burden and research prioritisation for these diseases, as well as COVID-19 and pandemic preparedness.
Dr Adeloye has served as an external PhD examiner for institutions in Africa, Australia, China, and the UK. He has over 100 publications in peer-reviewed journals and is currently the Editor in-Chief of the Journal of Global Health Reports and Associate Professor of Public Health at Teesside University, UK.